{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:54Z","timestamp":1791828594994,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,5]]},"DOI":"10.7759\/cureus.66169","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T10:05:34Z","timestamp":1722852334000},"source":"Crossref","is-referenced-by-count":7,"title":["Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome With Tofacitinib: A Case Report"],"prefix":"10.7759","author":[{"given":"Mustafa","family":"Alhayali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.05.006","article-title":"The SAPHO syndrome","volume":"42","author":"Nguyen MT","year":"2012","unstructured":"Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME. The SAPHO syndrome. Semin Arthritis Rheum. 2012, 42:254-65. 10.1016\/j.semarthrit.2012.05.006","journal-title":"Semin Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20912865","article-title":"Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update","volume":"12","author":"Liu S","year":"2020","unstructured":"Liu S, Tang M, Cao Y, Li C. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update. Ther Adv Musculoskelet Dis. 2020, 12:1759720X20912865. 10.1177\/1759720X20912865","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1560-x","article-title":"The SAPHO syndrome: a clinical and imaging study","volume":"30","author":"Sall\u00e9s M","year":"2011","unstructured":"Sall\u00e9s M, Oliv\u00e9 A, Perez-Andres R, Holgado S, Mateo L, Riera E, Tena X. The SAPHO syndrome: a clinical and imaging study. Clin Rheumatol. 2011, 30:245-9. 10.1007\/s10067-010-1560-x","journal-title":"Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2013.02.009","article-title":"SAPHO syndrome","volume":"39","author":"Carneiro S","year":"2013","unstructured":"Carneiro S, Sampaio-Barros PD. SAPHO syndrome. Rheum Dis Clin North Am. 2013, 39:401-18. 10.1016\/j.rdc.2013.02.009","journal-title":"Rheum Dis Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3751-1","article-title":"Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment","volume":"36","author":"Cianci F","year":"2017","unstructured":"Cianci F, Zoli A, Gremese E, Ferraccioli G. Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment. Clin Rheumatol. 2017, 36:2151-8. 10.1007\/s10067-017-3751-1","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.201260","article-title":"Clinical and radiological remission of osteoarticular and cutaneous lesions in SAPHO patients treated with secukinumab: a case series","volume":"48","author":"Wang L","year":"2021","unstructured":"Wang L, Sun B, Li C. Clinical and radiological remission of osteoarticular and cutaneous lesions in SAPHO patients treated with secukinumab: a case series. J Rheumatol. 2021, 48:953-5. 10.3899\/jrheum.201260","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-016-0583-y","article-title":"SAPHO syndrome: current developments and approaches to clinical treatment","volume":"18","author":"Firinu D","year":"2016","unstructured":"Firinu D, Garcia-Larsen V, Manconi PE, Del Giacco SR. SAPHO syndrome: current developments and approaches to clinical treatment. Curr Rheumatol Rep. 2016, 18:35. 10.1007\/s11926-016-0583-y","journal-title":"Curr Rheumatol Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200743","article-title":"Anakinra treatment of SAPHO syndrome: short-term results of an open study","volume":"71","author":"Wendling D","year":"2012","unstructured":"Wendling D, Prati C, Aubin F. Anakinra treatment of SAPHO syndrome: short-term results of an open study. Ann Rheum Dis. 2012, 71:1098-100. 10.1136\/annrheumdis-2011-200743","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2017.05.016","article-title":"IL-23\/Th17 targeted therapies in SAPHO syndrome. A case series","volume":"84","author":"Wendling D","year":"2017","unstructured":"Wendling D, Aubin F, Verhoeven F, Prati C. IL-23\/Th17 targeted therapies in SAPHO syndrome. A case series. Joint Bone Spine. 2017, 84:733-5. 10.1016\/j.jbspin.2017.05.016","journal-title":"Joint Bone Spine"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091086","article-title":"Tumor necrosis factor-alpha blockers in SAPHO syndrome","volume":"37","author":"Ben Abdelghani K","year":"2010","unstructured":"Ben Abdelghani K, Dran DG, Gottenberg JE, Morel J, Sibilia J, Combe B. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol. 2010, 37:1699-704. 10.3899\/jrheum.091086","journal-title":"J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.10.2008.1145","article-title":"Response to infliximab in SAPHO syndrome","volume":"2009","author":"Fruehauf J","year":"2009","unstructured":"Fruehauf J, Cierny-Modr\u00e8 B, Caelen Lel-S, Schwarz T, Weinke R, Aberer E. Response to infliximab in SAPHO syndrome. BMJ Case Rep. 2009, 2009:10.1136\/bcr.10.2008.1145","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217854","article-title":"Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome","volume":"81","author":"Xie W","year":"2022","unstructured":"Xie W, Huang H, Zhang Z. Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome. Ann Rheum Dis. 2022, 81:e91. 10.1136\/annrheumdis-2020-217854","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman MW","year":"2008","unstructured":"Karaman MW, Herrgard S, Treiber DK, et al.. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol. 2008, 26:127-32. 10.1038\/nbt1358","journal-title":"Nat Biotechnol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022793","article-title":"Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: a case report","volume":"99","author":"Kadoba K","year":"2020","unstructured":"Kadoba K, Waki D, Nishimura K, Mukoyama H, Saito R, Murabe H, Yokota T. Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: a case report. Medicine (Baltimore). 2020, 99:e22793. 10.1097\/MD.0000000000022793","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/art.39761","article-title":"Brief report: risk of gastrointestinal perforation among rheumatoid arthritis patients receiving tofacitinib, tocilizumab, or other biologic treatments","volume":"68","author":"Xie F","year":"2016","unstructured":"Xie F, Yun H, Bernatsky S, Curtis JR. Brief report: risk of gastrointestinal perforation among rheumatoid arthritis patients receiving tofacitinib, tocilizumab, or other biologic treatments. Arthritis Rheumatol. 2016, 68:2612-17. 10.1002\/art.39761","journal-title":"Arthritis Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg SR","year":"2022","unstructured":"Ytterberg SR, Bhatt DL, Mikuls TR, et al.. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med. 2022, 386:316-26. 10.1056\/NEJMoa2109927","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217250","article-title":"Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation","volume":"79","author":"Li Y","year":"2020","unstructured":"Li Y, Huo J, Cao Y, et al.. Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation. Ann Rheum Dis. 2020, 79:1255-7. 10.1136\/annrheumdis-2020-217250","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.911922","article-title":"SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report","volume":"13","author":"Yuan F","year":"2022","unstructured":"Yuan F, Luo J, Yang Q. SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report. Front Immunol. 2022, 13:911922. 10.3389\/fimmu.2022.911922","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S446468","article-title":"Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with baricitinib, a Janus kinase inhibitor","volume":"17","author":"Yang J","year":"2024","unstructured":"Yang J, Yuan C, Zhou S, Teng Z, Li M. Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with baricitinib, a Janus kinase inhibitor. Clin Cosmet Investig Dermatol. 2024, 17:529-37. 10.2147\/CCID.S446468","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2020.12.005","article-title":"Comparative analysis and differentiation between SAPHO syndrome and spondyloarthropathies using whole-spine MRI","volume":"76","author":"Zhang LH","year":"2021","unstructured":"Zhang LH, Han SB, Song L, Gao S, Zhao Q, Deng XL, Yuan HS. Comparative analysis and differentiation between SAPHO syndrome and spondyloarthropathies using whole-spine MRI. Clin Radiol. 2021, 76:394.e9-e14. 10.1016\/j.crad.2020.12.005","journal-title":"Clin Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275255-successful-treatment-of-refractory-synovitis-acne-pustulosis-hyperostosis-and-osteitis-sapho-syndrome-with-tofacitinib-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T10:05:37Z","timestamp":1722852337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275255-successful-treatment-of-refractory-synovitis-acne-pustulosis-hyperostosis-and-osteitis-sapho-syndrome-with-tofacitinib-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.66169","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,5]]}}}